IntrinsicIntrinsic
← Scroll for more →

Financial Statements — AKAN

Balance Sheet

(in millions USD)
MetricQ2 2025Q4 2024Q2 2024Q4 2023Q4 2022Q2 2022Q4 2021
Cash & Equivalents2.533.846.030.090.233.933.50
Inventory----1.291.291.060.900.00
Total Current Assets3.575.067.611.813.826.943.98
Total Non-current Assets2.652.862.357.0335.1836.544.07
Total Assets6.227.919.978.8439.0043.488.05
Total Current Liabilities2.843.645.4010.179.356.278.27
Total Non-current Liabilities*0.070.002.502.502.752.571.98
Total Liabilities2.913.645.4012.6712.108.8410.25
Retained Earnings(58.25)(57.46)(56.05)(53.36)(21.09)(12.02)(13.29)
Total Stockholder Equity3.304.284.57(3.83)26.9034.64(2.20)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2025Q2 2024Q4 2023Q2 2022
Total Revenue--0.48--0.07
Cost of Revenue*--0.30--(0.02)
Gross Profit--0.17--0.09
Selling, General & Admin0.320.502.121.18
Total Operating Expenses*1.492.53--11.01
Operating Income(1.49)(2.35)--(10.92)
Interest Expense--0.04----
Net Income(0.82)(2.68)--(2.59)
Basic EPS(1.17)(2.84)--(0.10)
Diluted EPS(1.17)(2.84)--(0.10)
← Scroll for more columns →

* Derived from reported values

Cash Flow Statement

(in millions USD)
MetricQ2 2025Q2 2024Q2 2022
Operating Cash Flow(0.38)(2.59)(8.35)
Investing Cash Flow0.000.10(4.23)
Financing Cash Flow(0.52)8.6414.64
← Scroll for more columns →